亚太地区血液透析和腹膜透析市场预测至 2028 年 - COVID-19 影响和按类型(血液透析和腹膜透析)、产品(设备、耗材和服务)和最终用户(医院和家庭)进行的区域分析????????????

Historic Data: 2020-2021   |   Base Year: 2022   |   Forecast Period: 2023-2028


No. of Pages: 73.    |    Report Code: BMIRE00025821    |    Category: Life Sciences

Asia Pacific Hemodialysis and Peritoneal Dialysis Market

亚太地区血液透析和腹膜透析市场预计将从2022年的192.552亿美元增长到2028年的299.7211亿美元;预计 2022 年至 2028 年复合年增长率为 7.7%。

 

对家庭护理透析的日益偏好是推动亚太地区血液透析和腹膜透析市场的主要因素。家庭血液透析 (HHD) 是一种针对终末期肾病 (ESKD) 患者的肾脏替代方式,可以在患者的家庭环境中安全地进行。它需要训练有素的护理人员或合格的血液透析护士的帮助。 HHD 的治疗频率可能因患者而异。 HHD 可以像传统 HHD 一样进行,每周治疗 3 天,每次 3 至 4 小时或更长时间。它也可以作为每日简短的 HHD 进行,每周进行 5 到 7 次,持续时间较短。最后,它可以作为夜间 HHD 进行过夜,治疗通常持续 6 至 8 小时。正在开发用于家庭血液透析的新型、易于使用的机器。它们更容易设置、清洁和消毒。尽管增加家庭透析的报销似乎是刺激这些方式采用的适当策略,但来自腹膜透析 (PD) 报销率高的地区的证据表明,该策略的成功率是可变的。

 

借助新功能和技术,供应商可以吸引新客户并扩大其在新兴市场的足迹。这一因素可能会推动亚太地区血液透析和腹膜透析市场的发展。亚太地区血液透析和腹膜透析市场预计在预测期内将以良好的复合年增长率增长。

 

 亚洲太平洋血液透析和腹膜透析到 2028 年的市场收入和预测(百万美元)

< strong> 

亚太地区血液透析和腹膜透析市场细分

 

亚太地区血液透析和腹膜透析市场按类型、产品、最终用户和国家/地区进行细分。根据类型,市场分为血液透析和腹膜透析。到2022年,血液透析领域预计将占据更大的市场份额。根据产品,血液透析和腹膜透析市场分为设备、耗材和服务。到 2022 年,服务领域可能会占据最大的市场份额。根据最终用户,市场分为医院和家庭。预计到 2022 年,以医院为基础的细分市场将占据更大的份额。根据国家/地区,亚太地区血液透析和腹膜透析市场分为澳大利亚、中国、印度、日本、韩国和亚太地区其他地区。预计到 2022 年,中国将占据最大的市场份额。

 

旭化成医疗有限公司; B. 布劳恩梅尔松根股份公司;百特国际公司;达维塔公司;迪亚莱夫公司;迪维鲁姆;费森尤斯医疗保健公司两合公司;尼普罗医疗公司;和 Rockwell Medical, Inc. 是亚太地区血液透析和腹膜透析市场的领先公司之一。


 ]所有文档清单:

 

1. 检查标题是否为标准格式。

2.所有文件中的基准年和预测期应保持一致

3. 不应发现市场名称和细分之间存在差异。

4. 相关文件中必须包含与新冠疫情影响相关的内容。

 [SM2]我们必须具体讨论在所考虑的市场中运营的公司。如果文件中提到的任何公司与市场无关,则应将其删除。请检查相关性。确保名称按照各自网站上给出的版权名称的正确性,特别是拼写、标点符号、前缀和后缀。



Asia Pacific Hemodialysis and Peritoneal Dialysis Strategic Insights

Strategic insights for Asia Pacific Hemodialysis and Peritoneal Dialysis involve closely monitoring industry trends, consumer behaviours, and competitor actions to identify opportunities for growth. By leveraging data analytics, businesses can anticipate market shifts and make informed decisions that align with evolving customer needs. Understanding these dynamics helps companies adjust their strategies proactively, enhance customer engagement, and strengthen their competitive edge. Building strong relationships with stakeholders and staying agile in response to changes ensures long-term success in any market.

strategic-framework/asia-pacific-hemodialysis-and-peritoneal-dialysis-market-strategic-framework.webp
Get more information on this report

Asia Pacific Hemodialysis and Peritoneal Dialysis Report Scope

Report Attribute Details
Market size in 2022 US$ 19,255.20 Million
Market Size by 2028 US$ 29,972.11 Million
Global CAGR (2022 - 2028) 7.7%
Historical Data 2020-2021
Forecast period 2023-2028
Segments Covered By 类型
  • 血液透析
  • 腹膜透析
By 产品
  • 设备
  • 消耗品
  • 服务
By 最终用户
  • 医院
  • 家庭
Regions and Countries Covered 亚太地区
  • 中国
  • 印度
  • 日本
  • 澳大利亚
  • 亚太其他地区
Market leaders and key company profiles
  • Asahi Kasei Medical Co., Ltd.
  • B. Braun Melsungen AG
  • Baxter International Inc.
  • DaVita Inc.
  • Dialife SA
  • Diaverum
  • Fresenius Medical Care AG & Co KGaA
  • Nipro Medical Corporation
  • Rockwell Medical, Inc
  • Get more information on this report

    Asia Pacific Hemodialysis and Peritoneal Dialysis Regional Insights

    The regional scope of Asia Pacific Hemodialysis and Peritoneal Dialysis refers to the geographical area in which a business operates and competes. Understanding regional nuances, such as local consumer preferences, economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved regions or adapting their offerings to meet regional demands. A clear regional focus allows for more effective resource allocation, targeted marketing, and better positioning against local competitors, ultimately driving growth in those specific areas.

    geography/asia-pacific-hemodialysis-and-peritoneal-dialysis-market-geography.webp
    Get more information on this report

    The List of Companies - Asia Pacific Hemodialysis and Peritoneal Dialysis Market

    1. Asahi Kasei Medical Co., Ltd.
    2. B. Braun Melsungen AG
    3. Baxter International Inc.
    4. DaVita Inc.
    5. Dialife SA
    6. Diaverum
    7. Fresenius Medical Care AG & Co KGaA
    8. Nipro Medical Corporation
    9. Rockwell Medical, Inc
    Frequently Asked Questions
    How big is the Asia Pacific Hemodialysis and Peritoneal Dialysis Market?

    The Asia Pacific Hemodialysis and Peritoneal Dialysis Market is valued at US$ 19,255.20 Million in 2022, it is projected to reach US$ 29,972.11 Million by 2028.

    What is the CAGR for Asia Pacific Hemodialysis and Peritoneal Dialysis Market by (2022 - 2028)?

    As per our report Asia Pacific Hemodialysis and Peritoneal Dialysis Market, the market size is valued at US$ 19,255.20 Million in 2022, projecting it to reach US$ 29,972.11 Million by 2028. This translates to a CAGR of approximately 7.7% during the forecast period.

    What segments are covered in this report?

    The Asia Pacific Hemodialysis and Peritoneal Dialysis Market report typically cover these key segments-

  • 类型 (血液透析, 腹膜透析)
  • 产品 (设备, 消耗品, 服务)
  • 最终用户 (医院, 家庭)
  • What is the historic period, base year, and forecast period taken for Asia Pacific Hemodialysis and Peritoneal Dialysis Market?

    The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the Asia Pacific Hemodialysis and Peritoneal Dialysis Market report:

  • Historic Period : 2020-2021
  • Base Year : 2022
  • Forecast Period : 2023-2028
  • Who are the major players in Asia Pacific Hemodialysis and Peritoneal Dialysis Market?

    The Asia Pacific Hemodialysis and Peritoneal Dialysis Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:

  • Asahi Kasei Medical Co., Ltd.
  • B. Braun Melsungen AG
  • Baxter International Inc.
  • DaVita Inc.
  • Dialife SA
  • Diaverum
  • Fresenius Medical Care AG & Co KGaA
  • Nipro Medical Corporation
  • Rockwell Medical, Inc
  • Who should buy this report?

    The Asia Pacific Hemodialysis and Peritoneal Dialysis Market report is valuable for diverse stakeholders, including:

    • Investors: Provides insights for investment decisions pertaining to market growth, companies, or industry insights. Helps assess market attractiveness and potential returns.
    • Industry Players: Offers competitive intelligence, market sizing, and trend analysis to inform strategic planning, product development, and sales strategies.
    • Suppliers and Manufacturers: Helps understand market demand for components, materials, and services related to concerned industry.
    • Researchers and Consultants: Provides data and analysis for academic research, consulting projects, and market studies.
    • Financial Institutions: Helps assess risks and opportunities associated with financing or investing in the concerned market.

    Essentially, anyone involved in or considering involvement in the Asia Pacific Hemodialysis and Peritoneal Dialysis Market value chain can benefit from the information contained in a comprehensive market report.